| Literature DB >> 755642 |
Abstract
Intravenous administration of erythro-1-(1-[2-(1,4-benzodioxan-2-yl)-2-OH-Et]-4-piperidyl)-2-benzimidazolinone (R-28935) (25--100 microgram/kg) produced a dose-related decrease in spontaneous electrical activity recorded in the splanchnic and renal nerves. Reductions in sympathetic nerve activity were paralleled by hypotension and bradycardia. R 28935-induced depressor responses were not affected by baroreceptor denervation, piperoxan, yohimbine or phentolamine. Results support the idea that R-28935 decreased resting blood pressure and heart rate through a reduction in central sympathetic outflow which does not involve alpha-adrenergic receptor activation.Entities:
Mesh:
Substances:
Year: 1978 PMID: 755642 DOI: 10.3109/10641967809068598
Source DB: PubMed Journal: Clin Exp Hypertens ISSN: 0148-3927 Impact factor: 1.749